drugset / Trial / NCT06151210
Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is to evaluate the efficacy and safety of DA-5219 in patients with acute or chronic gastritis
Timeline
- Start
- 2024-01-31
- Primary completion
- 2025-07-10
- Completion
- 2025-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-5219 | Unknown | — | — |
| Comparator | Stillen Tab. | Unknown | — | — |